SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Ernest Shackleton — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientErnest Shackleton
Date of birth1874-02-15
IdentifiersMRN HR-EX001-SYN-TD; SSN (made up) 000-01-7763
Document date1921-06-23
AuthorCormac Ellingsworth-Daly, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review of angina on medical therapy; decision about coronary angiography. [S]

History of Present Illness

Mr. Shackleton returns four weeks after his consultation. On metoprolol 100 mg his resting pulse is 60, but he still has chest tightness two or three times a week when he climbs the stairs carrying papers or walks fast into a cold wind, and he has used nitroglycerin four times. It never comes at rest. He has not smoked for five weeks. He is drinking within the limit he agreed. He sails in under three months, will be lifting and hauling at sea, and will be weeks from a hospital. He asked whether a stent would let him do that. He was uneasy about having a procedure that the backers might hear of, and said so; after talking it through he wants to go ahead. [S]

ElementDetail
AnginaTwo or three episodes a week despite metoprolol 100 mg
NitroglycerinUsed four times
TobaccoNot smoked for five weeks
GoalTo lead the expedition without angina limiting him

Review of Systems

SystemResultFinding
CardiovascularPositiveExertional angina unchanged in frequency; no rest pain or fainting
RespiratoryNegativeNo cough or breathlessness apart from the angina
GastrointestinalNegativeNausea on varenicline gone; no bleeding
MusculoskeletalNegativeNo muscle aches on the statin

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release tablet, one tablet by mouth dailyonce dailyOral route1921-05-12activeS
Atorvastatin 80 mg tablet, one tablet by mouth dailyonce dailyOral route1921-05-12activeS
Metoprolol succinate extended-release 50 mg tablet, one tablet by mouth dailyonce dailyOral route1921-05-12 to 1921-05-26stoppedS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeat every 5 minutes up to 3 dosesas needed for chest pain, up to 3 dosesSublingual route1921-05-12activeS
Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titrationtwice a day after titrationOral route1921-05-12activeS
Metoprolol succinate extended-release 100 mg tablet, one tablet by mouth dailyonce dailyOral route1921-05-26activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1921-06-23Body height175cmS
1921-06-23Body weight85kgS
1921-06-23Body mass index (BMI) [Ratio]27.8kg/m2S
1921-06-23Systolic blood pressure128mm[Hg]S
1921-06-23Diastolic blood pressure80mm[Hg]S
1921-06-23Heart rate60/minS
1921-06-23Respiratory rate14/minS
1921-06-23Body temperature36.6CelS
1921-06-23Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1921-06-23Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1921-06-23Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.74-1.35 mg/dLNormalS
1921-06-23Hemoglobin [Mass/volume] in Blood15.6g/dL13.2-17.1 g/dLNormalS
1921-06-23Platelets [#/volume] in Blood by Automated count24510*3/uL140-400 10*3/uLNormalS
1921-06-23Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1916)/1.73 sq M98mL/min/{1.73_m2}60 or moreNormalS

Physical Exam

Vital signs recorded on 1921-06-23; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 128/80, pulse 60, weight 85.0 kg
CardiovascularRegular rhythm; no murmur; both radial pulses normal, Allen test normal on the right
RespiratoryClear to auscultation bilaterally

Problems

ProblemClinical statusVerificationCodeProvenance
Chest tightness and breathlessness on exertion for about three months, brought on by stairs, carrying loads, and walking fast in cold wind and relieved within minutes by rest, never at rest; resting ECG normal; cause not yet established at intake; coronary CT angiography and cardiology consultation requestedresolvedconfirmed R07.89S — Synthetic presenting problem anchored to his documented exertional breathlessness; superseded by the diagnosis at the cardiology consultation.
Nicotine dependence, cigarettes: about 25 a day since 16 (about 39 pack-years)activeconfirmed F17.210S — Synthetic modern coding anchored to his documented heavy smoking.
Chronic coronary disease with stable exertional angina: 80% stenosis of the proximal left anterior descending artery with CT-FFR 0.70, mild right coronary artery disease, coronary calcium score 210, and normal left ventricular function; synthetic modern episode linked to his documented exertional illnesses and the coronary atheroma recorded at his deathactiveconfirmed I25.118S — Synthetic modern diagnosis made at the cardiology consultation; Macklin's coronary diagnosis is recorded in CLM-0009 and the alternative theories as R.
Hyperlipidemia: LDL cholesterol 168 mg/dL and HDL 38 mg/dL at intakeactiveconfirmed E78.5S — Synthetic modern risk factor; no historical measurement exists.
Prediabetes: HbA1c 5.9% at intakeactiveconfirmed R73.03S — Synthetic modern risk factor; no historical measurement exists.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure (target below 130/80 mmHg)Every visitCompleted today128/80 mmHg, at target
ExaminationWeight, BMI, and physical activityEvery visitCompleted today85.0 kg; walking more
ExaminationAngina frequency and Canadian Cardiovascular Society class, nitroglycerin useEvery visitCompleted todayClass II despite optimized beta-blocker; nitroglycerin four times
Medication safetyAdherence review: aspirin (or dual antiplatelet therapy), high-intensity statin, beta-blocker for anginaEvery visitCompleted todayAll taken daily; resting pulse 60 on metoprolol 100 mg
ImagingInvasive coronary angiography with a view to revascularizationFor angina that persists despite guideline-directed medical therapy, or by shared decisionOrderedBooked for next week after a shared decision
LaboratoryCreatinine, eGFR, potassium, hemoglobin, and platelets before angiographyBefore contrast and antiplatelet loadingCompleted todayCreatinine 0.96 mg/dL (eGFR 98), potassium 4.3 mmol/L, hemoglobin 15.6 g/dL, platelets 245 thousand per microliter
ImagingStress imaging, coronary CT angiography, echocardiography, or invasive angiographyOnly for new or worsening symptoms or a change in function despite optimized therapy; no routine surveillanceNot indicatedNo repeat noninvasive imaging; anatomy already defined
LaboratoryLipid panel4 to 12 weeks after starting or changing lipid therapy, then every 3 to 12 monthsDueAt ten weeks on atorvastatin, at the next visit
Self-managementTobacco use and cessation support (varenicline with counseling)Every visitCompleted todayAbstinent for five weeks
SurveyAlcohol use (AUDIT-C) and brief interventionEach visit until within limitsCompleted todayWithin the agreed limit by his report; AUDIT-C at the next visit
ReferralCardiac rehabilitation referralAt diagnosis of stable angina, and after PCIDeferredStill not made; to be made after the stent

Goal progress:

Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018)

Follow-up: Coronary angiography next week. Review three weeks after the procedure with a lipid panel. Next scheduled visit 1921-07-21: ten-week review: three weeks after the stent, lipids, cardiac rehabilitation, smoking and alcohol. [S]